Overbrook Management Corp Royalty Pharma PLC Transaction History

Overbrook Management Corp

$526 Million
Q2 2025

A detailed history of Overbrook Management Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Overbrook Management Corp holds 48,208 shares of RPRX stock, worth $1.79 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

48,208

Previous 58,408 17.46%

Holding current value

$1.79 Million

Previous $1.82 Million 4.51%

% of portfolio

0.33%

Previous 0.44%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$30.85 - $36.14 $314,670 - $368,628	-10,200 Reduced 17.46%	48,208 $1.74 Million
Q1 2025 Apr 24, 2025	SELL	$25.75 - $33.86 $1.55 Million - $2.03 Million	-60,000 Reduced 50.67%	58,408 $1.82 Million
Q4 2024 Jan 16, 2025	SELL	$24.28 - $28.39 $546,300 - $638,775	-22,500 Reduced 15.97%	118,408 $3.02 Million
Q3 2024 Nov 08, 2024	SELL	$25.63 - $29.27 $1.53 Million - $1.74 Million	-59,504 Reduced 29.69%	140,908 $3.99 Million
Q2 2024 Jul 25, 2024	SELL	$26.26 - $29.9 $234,685 - $267,216	-8,937 Reduced 4.27%	200,412 $5.28 Million
Q1 2024 Apr 15, 2024	SELL	$27.46 - $31.33 $283,606 - $323,576	-10,328 Reduced 4.7%	209,349 $6.36 Million
Q4 2023 Feb 02, 2024	SELL	$26.21 - $29.22 $2.07 Million - $2.31 Million	-79,035 Reduced 26.46%	219,677 $6.17 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $6.7 Million - $8 Million	-255,005 Reduced 46.05%	298,712 $8.11 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $741,953 - $916,412	-25,066 Reduced 4.33%	553,717 $17 Million
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $1 Million - $1.2 Million	-30,569 Reduced 5.02%	578,783 $20.9 Million
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $765,773 - $860,982	-19,550 Reduced 3.11%	609,352 $24.1 Million
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $2.84 Million - $3.18 Million	-71,169 Reduced 10.17%	628,902 $25.3 Million
Q2 2022 Aug 11, 2022	SELL	$37.53 - $44.22 $869,907 - $1.02 Million	-23,179 Reduced 3.2%	700,071 $29.4 Million
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $220,077 - $249,335	-5,875 Reduced 0.81%	723,250 $28.2 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $1.97 Million - $2.38 Million	-56,007 Reduced 7.13%	729,125 $29.1 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $1.01 Million - $1.18 Million	28,011 Added 3.7%	785,132 $28.4 Million
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $559,254 - $654,405	-14,034 Reduced 1.82%	757,121 $31 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $311,453 - $388,543	-7,356 Reduced 0.94%	771,155 $33.6 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $24.2 Million - $33.6 Million	670,759 Added 622.5%	778,511 $39 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $4.15 Million - $5.21 Million	107,752 New	107,752 $4.53 Million

Others Institutions Holding RPRX

# of Institutions

498

Shares Held

288M

Call Options Held

2.51M

Put Options Held

940K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $16.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Overbrook Management Corp with notifications on news.

Account

Overbrook Management Corp Royalty Pharma PLC Transaction History